Literature DB >> 2535958

Feline lymphomas: immunological and cytochemical characterization.

J L Rojko1, G J Kociba, J L Abkowitz, K L Hamilton, W D Hardy, J N Ihle, S J O'Brien.   

Abstract

The immunological and cytochemical phenotypes of five primary feline lymphomas and six feline lymphoma lines are reported. Thymic lymphomas induced by the Rickard strain of FeLV (FeLV-R) are of prothymocyte or (immature) cortical thymocyte origin, as these express terminal deoxynucleotidyl transferase, the guinea pig erythrocyte rosette receptor, Ia antigens, partial cortisone sensitivity, and nonspecific esterase. Lymphomas associated with other strains of FeLV form rosettes with guinea pig erythrocytes, frequently have Ia antigens and cytoplasmic nonspecific esterase, and probably originate from helper T-cells, monocyte/macrophages, or null cells. These data belie previous conclusions that FeLV leukemogenesis is restricted to mature T-cells; rather, the considerable heterogeneity in the surface and cytochemical phenotype of feline lymphomas probably reflects transformation of multipotent lymphoid or monocytoid precursors in the bone marrow by FeLV.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535958

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.

Authors:  P R Donahue; S L Quackenbush; M V Gallo; C M deNoronha; J Overbaugh; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.

Authors:  Chandtip Chandhasin; Patricia N Coan; Laura S Levy
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.

Authors:  P J Polas; C L Swenson; R Sams; C M Cheney; K A Hayes; M J Tarr; G J Kociba; L E Mathes
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

4.  A feline large granular lymphoma and its derived cell line.

Authors:  C M Cheney; J L Rojko; G J Kociba; M L Wellman; S P Di Bartola; L J Rezanka; L Forman; L E Mathes
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

5.  Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.

Authors:  M L Jackson; S L Wood; V Misra; D M Haines
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

6.  Worldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspects.

Authors:  R A Olmsted; R Langley; M E Roelke; R M Goeken; D Adger-Johnson; J P Goff; J P Albert; C Packer; M K Laurenson; T M Caro
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

7.  Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.

Authors:  R Pandey; A K Ghosh; D V Kumar; B A Bachman; D Shibata; P Roy-Burman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo.

Authors:  U Truyen; C R Parrish
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins.

Authors:  B S Kristal; T A Reinhart; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma.

Authors:  M L Jackson; D M Haines; S M Meric; V Misra
Journal:  Can J Vet Res       Date:  1993-10       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.